TrialBMJ open2017

Randomised controlled trial comparing ofatumumab to rituximab in children with steroid-dependent and calcineurin inhibitor-dependent idiopathic nephrotic syndrome: study protocol.

Pietro Ravani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.